Platelet agonist synergism by the acute phase reactant C-reactive protein.

C-reactive protein is the prototypic acute phase reactant. A self-complexed form (H-CRP) can induce isolated platelets to undergo aggregation, secretion of dense and alpha-granule constituents, and generation of thromboxane A2, but fails to function in platelet-rich plasma (PRP) as a direct agonist. In contrast, when PRP was activated with an amount of adenosine diphosphate (ADP) that produced only reversible platelet aggregation, the presence of H-CRP resulted in irreversible aggregation and the secretion of adenosine triphosphate (ATP). Following a maximum stimulus with ADP alone, where platelet secretion occurred late during the aggregation response, the presence of H-CRP shifted and increased the secretory burst to a time simultaneous with the onset of aggregation. This hypersecretion required H-CRP to be present prior to platelet stimulation or to be added within 15 to 30 seconds following the addition of ADP. H-CRP also potentiated platelet activation stimulated with epinephrine, thrombin, and collagen. When the synergism generated in PRP by H-CRP in the presence of ADP or epinephrine was compared to the synergism similarly produced by aggregated human IgG, collagen, or thrombin, it more closely resembled that of collagen, as reflected by the kinetics and characteristics of synergism and sensitivity to creatine phosphate/creatine phosphokinase or 5,8,11,14-eicosatetraynoic acid. These data provide a philosophically ideal niche for the acute phase (and C-reactive protein) in that a platelet-directed activity associated with this acute phase reactant is not utilized unless platelets are otherwise challenged.

[1]  K. Hedman,et al.  Binding of fibronectin by the acute phase reactant C-reactive protein. , 1984, The Journal of biological chemistry.

[2]  H. Gewurz,et al.  Selective inhibition of platelet activation by the amyloid P-component of serum. , 1983, Journal of immunology.

[3]  R. M. Simpson,et al.  Comparison of the enzymatic sensitivities of the platelet receptor for human C-reactive protein and its functional relationship to the platelet IgG Fc receptor. , 1982, Clinical and experimental immunology.

[4]  R. M. Simpson,et al.  Generation of thromboxane A2 and aorta-contracting activity from platelets stimulated with modified C-reactive protein. , 1982, Immunology.

[5]  R. M. Simpson,et al.  Activation of platelets by modified C-reactive protein. , 1982, Immunology.

[6]  M. Benson,et al.  C-reactive protein and the acute-phase response. , 1981, The Journal of laboratory and clinical medicine.

[7]  T. Detwiler,et al.  Characteristics of the synergistic actions of platelet agonists. , 1981, Blood.

[8]  L. Culp,et al.  Evidence that fibronectin is the collagen receptor on platelet membranes. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[9]  H. Holmsen Prostaglandin Endoperoxide – Thromboxane Synthesis and Dense Granule Secretion as Positive Feedback Loops in the Propagation of Platelet Responses during “The Basic Platelet Reaction” , 1977, Thrombosis and Haemostasis.

[10]  J. Mustard,et al.  Synergism between platelet aggregating agents: the role of the arachidonate pathway. , 1977, Thrombosis research.

[11]  R. Feinman,et al.  Interrelations of platelet aggregation and secretion. , 1977, The Journal of clinical investigation.

[12]  N. Aoki,et al.  Potentiation by collagen or epinephrine of platelet responsiveness to aggregation. The possible role of substance(s) released from platelet membranes. , 1977, The Journal of laboratory and clinical medicine.

[13]  S. Pfueller,et al.  Studies of the mechanism of the human platelet release reaction induced by immunologic stimuli. III. Relationship between the binding of soluble IgG aggregates to the Fc receptor and cell response in the presence and absence of plasma. , 1977, Journal of immunology.

[14]  H. Movat,et al.  Platelet Aggregation and Release of ADP, Serotonin and Histamine Associated with Phagocytosis of Antigen-Antibody Complexes.∗ , 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[15]  Thomas Francis,et al.  SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS , 1930, The Journal of experimental medicine.

[16]  R. M. Simpson,et al.  Platelet inhibitory effects of CRP preparations are due to a co-isolating low molecular weight factor. , 1982, Immunology.